Latest Siox News
Jun 15, 2021
The stock price of Sio Gene Therapies Inc (NASDAQ: SIOX) increased by over 15% pre-market. This is why it happened. The stock price of Sio Gene Therapies Inc (NASDAQ: SIOX) increased by over 15% pre-market. Investors are responding positively to a bullish research report. BTIG analyst Yun Zhong initiated coverage of Sio Gene Therapies with a “Buy” rating. And Zhong assigned the company an $8 price target. The $8 price target represents a 221.29% upside to the company shares. Zhong believes that the 3 clinical-stage gene therapy programs that Sio licensed from partners enable the company to jumpstart its transformation process. And the progress that the company achieved in each program is expected to support its continued growth into a strong gene therapy pure play. Disclaimer: This content is intended for informational purposes. Before making any investment, you should do your own analysis.